This overactivated GSK3β can then phosphorylate insulin receptor substrate 1 (IRS1) at the Ser332 site, impairing insulin signaling and contributing to insulin resistance, a condition often associated with diabetic nephropathy [100]. This evidence concerns the gene GSK3B and Insulin resistance.